SCHEMBL30093044

SCHEMBL30093044

Cc1ccc(NC(=O)CNc2ccccc2C(=O)NCc2ccco2)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.77
HPGD P15428 5/20 0.77
ALDH1A1 P00352 5/20 0.77
SMN1; SMN2 Q16637 4/20 0.58
TSHR P16473 2/20 0.57
HSD17B10 Q99714 2/20 0.57
TDP1 Q9NUW8 3/20 0.55
NPC1 O15118 2/20 0.55
RAB9A P51151 2/20 0.55
USP2 O75604 1/20 0.54
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
HTT P42858 2/20 0.53
MAPT P10636 2/20 0.52
NPSR1 Q6W5P4 2/20 0.52
CASP3 P42574 1/20 0.52
SENP7 Q9BQF6 1/20 0.52
SENP6 Q9GZR1 1/20 0.52
POLB P06746 3/20 0.51
TP53 P04637 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23412452 1.00 KDM4E (0.77) KDM4EHPGDALDH1A1SMN1; SMN2TSHR
SCHEMBL25061002 0.91 HPGD (0.76) KDM4EHPGDALDH1A1SMN1; SMN2TSHR
SCHEMBL30092936 0.90 HPGD (0.71) KDM4EHPGDALDH1A1SMN1; SMN2TSHR
SCHEMBL23412448 0.90 HPGD (0.71) KDM4EHPGDALDH1A1SMN1; SMN2TSHR
SCHEMBL29845739 0.89 HPGD (0.70) KDM4EHPGDALDH1A1SMN1; SMN2TSHR
SCHEMBL23413032 0.89 HPGD (0.70) KDM4EHPGDALDH1A1SMN1; SMN2TSHR
SCHEMBL30093114 0.85 HPGD (0.68) KDM4EHPGDALDH1A1SMN1; SMN2TSHR
SCHEMBL23413171 0.85 HPGD (0.68) KDM4EHPGDALDH1A1SMN1; SMN2TSHR
SCHEMBL23412447 0.85 ALDH1A1 (0.73) KDM4EHPGDALDH1A1SMN1; SMN2TSHR
SCHEMBL29846067 0.85 ALDH1A1 (0.73) KDM4EHPGDALDH1A1SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115397806-A Aryl and heteroaryl compounds and their therapeutic use in conditions associated with altered activity of galactocerebrosidase 增益治疗股份有限公司 2022-11-25 CN disclosed